Skip to main content
. 2021 Dec 16;8:793040. doi: 10.3389/fmed.2021.793040

Figure 5.

Figure 5

MM-EV effect on CXCR4 expression on HSPCs. Percentage of CXCR4 expression on CD34+, CD34+/CD38, and CD34+/CD38+ cells after 20 h of treatment with two doses of MM-derived EVs (MM-EVs 200 μg, MM-EVs 400 μg). The bar graphs represent the average with standard deviation from three independent experiments. MM, multiple myeloma; EVs, Extracellular vesicles; HSPC, hematopoietic stem and progenitor cells.